申请人:AstraZeneca AB
公开号:US20140206677A1
公开(公告)日:2014-07-24
Compounds of formula (I), pharmaceutically acceptable salts thereof, and uses of the compounds of formula (I) for treating bacterial infections are disclosed.
化合物的结构式(I),其药学上可接受的盐,以及利用该结构式(I)化合物治疗细菌感染的用途被披露。